| Presence Home Care-kankakee | |
| 179 E Bethel Drive, Bourbonnais, Illinois 60914 | |
| (815) 937-2475 | |
| Name | Presence Home Care-kankakee |
|---|---|
| Location | 179 E Bethel Drive, Bourbonnais, Illinois |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 147105 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 60194, 60401, 60408, 60416, 60420, 60424, 60430, 60442, 60449, 60468, 60475, 60481, 60901, 60910, 60911, 60912, 60913, 60914, 60915, 60917, 60919, 60922, 60924, 60927, 60930, 60931, 60935, 60938, 60940, 60941, 60944, 60950, 60951, 60953, 60954, 60955, 60958, 60961, 60964, 60966, 60968, 60970 |
| NPI Number | 1134178338 |
| Organization Name | PRESENCE HOME CARE |
| Doing Business As | PRESENCE HOME CARE - KANKAKEE |
| Address | 179 E Bethal Dr, Bourbonnais, IL 60914 |
| Phone Number | 815-937-2475 |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
| Quality Rating: |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.2 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 98.1 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 63.7 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 77.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.5 | 79.6 |
| How often patients got better at getting in and out of bed | 81.9 | 81.1 |
| How often patients got better at bathing | 82.2 | 82.3 |
| How often patients’ breathing improved | 86.8 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.4 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 78.1 | 75 |
| How often home health patients had to be admitted to the hospital | 17.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.7 | 94 |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
The patient survey data of Presence Home Care-kankakee is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 88 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
Eli Lilly and Company's enzastaurin, an investigational, multi-targeted therapy that is currently the focus of two global Phase III clinical trials, one for the treatment of glioblastoma and one in non-Hodgkin's lymphoma
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.
› Verified 5 days ago
Presence Home Care-kankakee Location: 179 E Bethel Drive, Bourbonnais, Illinois 60914 Ratings: Phone: (815) 937-2475 |